🔴 Xenetic Biosciences is trading 5.6% down in pre-market with no clear catalyst

Xenetic Biosciences is trading 5.58% down at $3.12 in pre-market, with no company-specific announcement identified for August 13, 2026.

• The latest disclosure was the August 7 second-quarter report.
• It showed an approximately $0.9 million net loss and $6.5 million in cash, but does not directly explain the decline.
• Broader markets are nearly flat, with no clear macro catalyst.